MedTrace Logo

Systemic Mechanisms in Allergic Rhinitis: Assessment of Metabolomic Outcomes.

NCT02230475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2015-04-21

No results posted yet for this study

Summary

This clinical study will use the Environmental Exposure Unit (EEU) to generate allergic rhinitis symptoms in participants under controlled conditions, to collect well-characterized biological samples (urine and blood) before and after they develop these symptoms. The EEU provides the ability to control the timing, duration and levels of allergen exposure, and also other outside environmental factors, yielding ideal biologic samples for analysis with novel, cutting-edge molecular techniques. Results from the analysis of these unique allergic rhinitis samples should help determine if the technique of urine Nuclear Magnetic Resonance analysis could be a useful diagnostic tool in allergic rhinitis. IgE testing will be done on blood samples and compared to spin prick testing and symptoms of allergic rhinitis.

Conditions

  • Allergic Rhinitis

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Anne K Ellis, MD MSc FRCPC · Queen's University

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02230475 on ClinicalTrials.gov